Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.
作者:
DOI
10.1016/j.lanepe.2023.100741
PMID
37927438
发布时间
2025-01-15
- 浏览0
The Lancet regional health. Europe
2023年34卷
100741页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文